NEWSROOM

medical

SS Innovations International, Inc. (f/k/a Avra Medical Robotics, Inc.) Commences Trading under “SSII” Ticker Symbol and Provides Corporate Update

May 15, 2023

SSII is a Developer of Innovative, Affordable and Accessible Surgical Robotic Technologies Fort Lauderdale, FL, May 15, 2023 -- McapMediaWire -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population, today released a corporate update. Recent Highlights Effective with the open of...

RemSleep Holdings Inc. Provides Shareholder Update

Apr 26, 2023

Tampa, FL, April 26, 2023 -- McapMediaWire -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) patients, provides an update on its testing protocol for 510K clearance of its DeltaWave CPAP Mask as well as positive developments for its next generation masks which have shown internal indications of relief from those suffering with certain comorbidities in conjunction with their sleep...

AVRA Medical Robotics Announces Closing of Merger with CardioVentures

Apr 19, 2023

Announces Management Changes and Name Change to SS Innovations International, Inc. Fort Lauderdale, FL, April 19, 2023 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“the Company”) (OTC: AVMRD), a medical robotics software and artificial intelligence company, announced that it has closed on its previously announced acquisition by merger of CardioVentures, Inc. The Company also announced that in connection with the closing of the merger, the Company changed its corporate name to SS...

Summary of Concussion

Mar 30, 2023

Phoenix, Arizona, March 30, 2023 Introduction Have you ever hit your head and felt a little dizzy or confused afterwards? If so, you may have experienced a concussion. A concussion is a type of brain injury caused by a blow to the head or a violent shaking of the head and body. It is a common injury, particularly among athletes and those who engage in high-impact activities. In this article, we'll explore what a concussion is, its causes, symptoms, diagnosis, treatment, recovery,...

Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment

Mar 30, 2023

Las Vegas, NV, March 30, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on creating unique, life-enhancing medical products, is developing a novel neuropharmaceutical treatment for mild Traumatic Brain Injury (mTBI) also known as a concussion. Recently, the world’s leading research agency, the National Institutes of Health (NIH), acknowledged that Chronic Traumatic Encephalopathy (CTE) is caused by repetitive head...

Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment

Mar 30, 2023

Las Vegas, NV, March 30, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on creating unique, life-enhancing medical products, is developing a novel neuropharmaceutical treatment for mild Traumatic Brain Injury (mTBI) also known as a concussion. Recently, the world’s leading research agency, the National Institutes of Health (NIH), acknowledged that Chronic Traumatic Encephalopathy (CTE) is caused by repetitive head trauma,...

Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research

Feb 7, 2023

Las Vegas, NV, Feb 07, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announces a Community-Based Partnership (CBP) with the David R. Metcalf Invisible Wounds Foundation, a non-profit organization that advances brain health care for active duty military and veterans by addressing traumatic brain injury (TBI) and suicide prevention among Naval Special Warfare...

HMNU CORPORATE UPDATE ON ITS REAL ESTATE CRYPTO TOKEN AND ANNOUNCEMENT OF NEW BOARD MEMBER FROM ITS HEALTHCARE JOINT VENTURE NEUTEL SRL

Jan 12, 2023

Boston, Massachusetts, January 12, 2023 - McapMediaWire - Human Unitec International, Inc., (OTC Pink: HMNU) ("HMNU"), is a Project Finance, Management & Development Company for Sustainability, Medical, Wellness, and Green Energy, announces strategic Letter of Intent for Exclusive License Agreement for its HMNU Medical Division. The Company has placed a hold on its Blockchain Property Token, BCPE, due to the dramatic decline in cryptocurrencies over the past four months. BCPE has...

Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote

Jan 12, 2023

Las Vegas, NV, January 12, 2023 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, announces the launch of a concept phase to develop an intra-nasal field-deliverable nerve agent antidote. Chemical warfare using organophosphate nerve agents is a threat worldwide. The risk could not be higher for civilians and military personnel operating in conflict areas like Ukraine. Nerve...

RemSleep Holdings Inc. Issues Letter to Shareholders

Jan 6, 2023

Tampa, FL, January 6, 2023 -- McapMediaWire -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, today provides a corporate update and letter to shareholders from CEO Tom Wood. Dear RemSleep Shareholders, 2023 is shaping up to be an extremely pivotal year for RemSleep and I couldn’t be more excited for the Company due to how we are currently positioned going into the New Year....

Odyssey Health, Inc. Provides a Year End Update on Company and Corporate Outlook for 2023

Dec 19, 2022

Las Vegas, NV, December 19, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing life-enhancing medical products, today presents a Company update and recap of its product development programs. The Company has medical products in development which it intends to move forward in their respective clinical programs with the goal of FDA submission and commercialization. “We are extremely pleased with the progress our...

AVRA Medical Robotics, Inc. (OTC: AVMR) PROVIDES UPDATE ON MERGER

Dec 14, 2022

ORLANDO, FL, December 14, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR), a medical robotics software and artificial intelligence company announced that it is continuing to progress to consummation of its acquisition by merger of CardioVentures, Inc. (“CardioVentures”), as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022. CardioVentures holds an indirect controlling interest in an Indian private limited...

AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status

Dec 1, 2022

ORLANDO, FL, December 01, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announced that as of November 30, 2022, it has filed all required periodic reports with the Securities and Exchange Commission and accordingly is current in its filing SEC status. The Company is progressing to consummation of its acquisition by merger of CardioVentures, Inc, as previously reported in its Current Report on Form 8-K filed with the SEC on November 7, 2022....

Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development

Nov 23, 2022

Las Vegas, NV, November 23, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a Company update and recap of its concussion drug development program. Concussions represent an ‘unmet’ medical need and affect tens of millions worldwide. Odyssey acquired the intellectual property and all rights to the concussion drug in March 2021. Since the acquisition, Odyssey...

Human Unitec Provides Corporate Update on Deployment Medical Equipment in Italy & Europe and update on Neutel srl contract

Nov 15, 2022

Boston, Massachusetts, November 15, 2022 - McapMediaWire - Human Unitec International, Inc. (OTC: HMNU) announce the new management and deployments of our HMNU Medical Equipment in Italy. We have added the following medical professional teams with Prof. Francesco Braconaro as Medical Director, Dr. Ghazy S.Amir, as a Training and Assistance Department Director, and Prof. Luciano Lanfranchi as Medical Aesthetic Department Director. The medical teams are now organized to give to the...

Odyssey Health, Inc. Schedules Annual Meeting of Stockholders

Nov 15, 2022

Las Vegas, NV, November 15, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, today announced it plans to hold the Annual Meeting of Stockholders of Odyssey Health, Inc. on January 12, 2023. To be considered at the annual meeting, any stockholder proposals must be received at the principal executive offices of the Company, 2300...

RemSleep Holdings Provides a Corporate Update on Testing

Nov 8, 2022

Tampa, FL, November 08, 2022 -- McapMediaWire -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever improving the level of treatment provided to obstructive Sleep Apnea patients, is pleased to announce that the expected last battery of testing will commence this week for final FDA submission of the company’s signature DeltaWave mask. The series of additional tests that were identified in the prior GXP analysis are expected to take approximately 14-18...

AVRA Medical Robotics, Inc. (OTC: AVMR) Files More Patents

Nov 3, 2022

ORLANDO, FL, November 03, 2022 -- McapMediaWire -- AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update: In October 2022, AVRA’s patent counsel, Locke Lord LLP, filed an additional patent application related to the Company’s semi-automated robotic system. Locke Lord LLP had previously responded to the US Patent Office on a prior patent application the Company had made that covered various apparatus and methods for its semi-automated robotic...

Odyssey Health Inc. Strengthens Commitment to Odyssey NeuroPharma Through Expansion of Executive Team

Nov 3, 2022

Las Vegas, NV, November 03, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, is pleased to announce its continued commitment to the newly formed entity, Odyssey NeuroPharma, with the expansion of its executive team. Joining the executive team at Odyssey NeuroPharma to advance Odyssey’s concussion treatment, and Niemann-Pick...

Odyssey Health Inc. Files Full US Patent Application on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device

Nov 1, 2022

Las Vegas, NV, November 01, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc. (the "Company" or "Odyssey"), announces that it has filed for United States and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device (“Nasal Device”). As announced, Odyssey’s recently completed Phase I study to treat concussion successfully used Odyssey’s Nasal Device and drug combination. Odyssey designed the Nasal Device with...

Odyssey Health, Inc. Forms Pharmaceutical Subsidiary Focused on Treating Neurological Diseases

Oct 11, 2022

Las Vegas, NV, October 11, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, announces the formation of Odyssey Neuropharma, Inc., a wholly owned subsidiary, focused on developing drugs to treat neurological disorders. The blood-brain barrier (BBB) represents a significant obstacle for drug delivery to the brain. Many drugs have failed in neuroscience research due to the...

Odyssey Health, Inc. Provides Recap on Concussion Drug Development

Oct 6, 2022

Las Vegas, NV, October 6, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a recap of their concussion drug development program. Concussions represent an ‘unmet’ medical need and affect millions worldwide. Repetitive concussions can increase the risk of developing Chronic Traumatic Encephalopathy (CTE) and other neuropsychiatric disorders. Odyssey acquired...

HMNU ANNOUNCE LETTER OF INTENT FOR ASSIGNMENT OF EXCLUSIVE LICENSE FOR HOSPITAL, PORT AND AIRPORT SOLID WASTE STERILIZERS AND JOINT VENTURE WITH NEUTEL SRL

Oct 5, 2022

Champlain, New York, October 5, 2022 - McapMediaWire - Human Unitec International, Inc. (OTC Pink: HMNU) (“HMNU”) is a Project Finance, Management & Development Company for Sustainability, Medical, Wellness, and Green Energy, announces strategic Letter of Intent for Exclusive License Agreement for its HMNU Medical Division. Human Unitec international is please to announce the subscription of binding letter of intent for the Exclusive License for Hospital, Port and Airport...

Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program

Sep 30, 2022

Las Vegas, NV, Sept. 30, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing a unique drug to treat concussion has decided to dissolve its sports advisory board. The sports advisory members have been outspoken advocates for concussion prevention and for the importance of finding responsible treatments. We created the advisory board to increase awareness of our mission to bring a much-needed pharmaceutical for a...

Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug

Sep 28, 2022

Las Vegas, NV, Sept. 28, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announces the completion of all cohorts for its Phase I Single Ascending Dosing (SAD) and Multiple Ascending Dosing (MAD) clinical trial. Odyssey’s trial involved administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. Throughout the trial, the drug was...

HUMAN UNITEC INTERNATIONAL INC CORPORATE UPDATE ON MARKETING AGREEMENTS FOR ITS HMNU-MSK KINESIS MEDICAL

Sep 27, 2022

Champlain, New York, September 27, 2022 - McapMediaWire - Human Unitec International, Inc. (OTC Pink: HMNU) (“HMNU”) is a Project Finance, Management & Development Company for Sustainability, Medical, Wellness, and Green Energy, announces three strategic marketing agreements for its HMNU-MSK Kinesis Medical Equipment. The Company is pleased to announce the delivery of the first shipment of 15 medical and wellness units to its exclusive agents in Italy in order to begin...

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II

Sep 13, 2022

Las Vegas, NV, Sept. 13, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today announced the successful completion of safety measures for the second cohort of their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects to determine drug safety. For...

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial

Aug 18, 2022

Las Vegas, NV, August 18, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International Inc., a company focused on developing unique, life-enhancing medical products, today announced the successful completion of safety measures for their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects. For MAD Cohort I, the drug was safe and well...

Odyssey Health, Inc. Announces Positive Results from Its Phase I Multi-Day Ascending Dosing for the Treatment of Concussion

Aug 10, 2022

Las Vegas, NV, August 10, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-improving medical products, today announces the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (MAD) arm for its Phase I Clinical Trial. Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. MAD Cohort I subjects were dosed for five...

Odyssey Health, Inc. Launches New Corporate Website

Aug 4, 2022

Las Vegas, NV, August 04, 2022 -- McapMediaWire -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, a company focused on developing unique, life-saving medical products, is pleased to announce the launch of its new innovative corporate website: https://www.odysseyhealthinc.com/. The new corporate website, like the Company’s previously announced name change, was designed to not only better reflect Odyssey Health’s mission and focus, but also improve communication...

Categories

Mcap MediaWire - Costumer Service

Translate »